Cell Therapy

The cell therapy oncology market is expected to reach $30bn by 2030. (Image: iStock)

GE acquires stem cell supplier Biosafe

By Melissa Fassbender

GE Health has acquired Biosafe in a move that it says will enable production of cell and gene therapies on an industrialized scale.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers